Segment Information (Tables)

6 Months Ended

Dec. 31, 2014

Schedule of segment performance measures

Six Months Ended December 31, 2014 and 2013:


	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2014
Net sales	$	104,503	$	70,556	$	79,509	$	-		$	254,568
Gross profit		30,872		13,076		13,722		-			57,670
Income (loss) before income taxes		12,429		3,860		4,820		(2,979	)		18,130

2013
Net sales	$	78,511	$	85,903	$	81,355	$	-		$	245,769
Gross profit		24,168		23,035		13,515		-			60,718
Income (loss) before income taxes		11,727		14,530		5,453		(3,406	)		28,304

Three months Ended December 31, 2014 and 2013:


	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2014
Net sales	$	55,424	$	32,579	$	35,762	$	-		$	123,765
Gross profit		16,331		6,926		6,762		-			30,019
Income (loss) before income taxes		6,972		2,327		2,896		(1,710	)		10,485

2013
Net sales	$	39,817	$	37,479	$	39,212	$	-		$	116,508
Gross profit		13,027		7,773		6,184		-			26,984
Income (loss) before income taxes		6,192		3,526		2,151		(1,139	)		10,730

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details